Deformulation analysis for pharmaceutical and biological products
Reverse engineering, also known as deformulation or reverse chemical engineering, is an advanced analytical process that enables the identification and quantification of all components within a formulation, including active pharmaceutical ingredients (APIs) and excipients.
At Netpharmalab, we provide comprehensive deformulation studies based on high-resolution chromatographic and spectrometric techniques, delivering in-depth, reliable characterization aligned with regulatory requirements.
This service is commonly used to replicate existing products, obtain detailed insights into competitor products or alternative brands, detect discrepancies between different production batches, and troubleshoot failures in complex formulations.
Deformulation services can be applied to analyze and reconstitute a wide range of products, including solid oral dosage forms, injectables, topical formulations, and even controlled-release products.
What is Reverse Engineering and Pharmaceutical Deformulation?
Deformulation involves analyzing a formulation to determine:
- The identity of its components (Q1)
- The exact quantity of each component (Q2)
- The complete formulation profile
This process enables a detailed understanding of the composition of complex pharmaceutical products from both qualitative and quantitative perspectives.
The Challenge of Formulation Analysis
Pharmaceutical products present several challenges, including:
- Complex formulations with multiple excipients
- Interactions between components
- Batch-to-batch variability
- Sensitivity to environmental factors
Without an advanced analytical approach, it is difficult to obtain accurate and reproducible information.
Comprehensive Formulation Characterization
At Netpharmalab, we apply an integrated approach that combines:
- Advanced chromatographic techniques
- High-resolution mass spectrometry
- Robust quantitative methods
This enables a comprehensive characterization of the product, including its behavior under exposure to:
- Humidity
- Temperature
- Photodegradation
What Does the Reverse Engineering and Deformulation Service Include?
- Qualitative identification (Q1) of components
- Quantification (Q2) of APIs and excipients
- Complete formulation profile
- Comparative analysis between products
- Stability and degradation assessment
Main Applications of Reverse Engineering and Deformulation
- Formulation development and optimization
- Benchmarking against competitor products
- Biosimilar and generic studies
- Patent infringement investigations
- Batch-to-batch variability assessment
- Failure analysis and product troubleshooting
Types of Products Analyzed
Our deformulation studies are applied to:
- Solid oral dosage forms
- Injectables
- Topical formulations
- Controlled-release systems
- Complex biological products
Technologies and Methodologies Used
- Chromatography (HPLC, GC)
- Mass spectrometry (LC-MS, HRMS)
- Advanced separation techniques
- Validated quantitative methods
Regulatory Compliance
Our studies are aligned with:
- EMA (European Medicines Agency)
- FDA (Food and Drug Administration)
- ICH (International Council for Harmonisation)
Ensuring results that are suitable for development purposes and regulatory submissions.
Frequently Asked Questions (FAQ)
- What is the difference between deformulation and conventional testing?: Deformulation aims to identify and quantify all components of a formulation, rather than analyzing a single specific parameter.
- Can unknown excipients be identified?: Yes, advanced analytical techniques enable the identification of undeclared excipients and compounds.
- What is the role of deformulation in generics or biosimilars?: It allows for formulation comparison and helps ensure equivalence with reference products.
- Can batch-to-batch differences be detected?: Yes, it is a key tool for assessing variability and consistency.
- Are these studies suitable for regulatory processes?: Yes, provided they are conducted in accordance with EMA, FDA, and ICH standards.
GMP